hodgkin
No description yet: the sentence for this tag has not been written. 4 records carry it: 4 people.
4 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Andreas Engert Professor of Internal Medicine, Hematology and Oncology, University Hospital Cologne; former Chair, German Hodgkin Study Group · Uniklinik Köln (CIO) Led the GHSG for two decades, running the HD10 to HD18 trials that cure over 90% of Hodgkin lymphoma with less treatment. | Hodgkin lymphoma | none | ghsg, de-escalation | ||
Joseph M. Connors Clinical Professor Emeritus, BC Cancer Centre for Lymphoid Cancer, University of British Columbia · BC Cancer Led ECHELON-1, which replaced bleomycin with brentuximab vedotin in first-line advanced Hodgkin lymphoma. | Hodgkin lymphoma | none | adc, canada | ||
Kara M. Kelly Chair of Pediatric Oncology, Roswell Park Comprehensive Cancer Center; Division Chief, Pediatric Hematology/Oncology, University at Buffalo · Roswell Park Comprehensive Cancer Center Leads the COG Hodgkin lymphoma committee and the trials bringing brentuximab and nivolumab to children with the disease. | Hodgkin lymphoma | none | paediatric, cooperative-group | ||
Peter Borchmann Professor of Medicine and Head of the German Hodgkin Study Group, University Hospital Cologne · Uniklinik Köln (CIO) Leads the German Hodgkin Study Group and HD21, which made BrECADD the most effective and least toxic regimen for advanced Hodgkin lymphoma. | Hodgkin lymphoma | none | ghsg, trialist |
